Sugi Predict

Sugi Predict / Compounds / SCHEMBL2186789

SCHEMBL2186789

SCHEMBL2186789

COc1cnc(C(C)=O)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ F2 P00734 2/20 0.42
▸ GLA P06280 1/20 0.42
▸ CYP3A4 P08684 3/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ CES2 O00748 1/20 0.37
▸ CES1 P23141 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ MAPT P10636 1/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ MTNR1A P48039 2/20 0.35
▸ MTNR1B P49286 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10328697 0.82 CA1 (0.45) ALDH1A1HPGDF2GLASMN1; SMN2
SCHEMBL25405562 0.80 ALDH1A1 (0.45) ALDH1A1HPGDF2GLACYP3A4
SCHEMBL15264511 0.80 CA1 (0.47) ALDH1A1HPGDF2GLACYP3A4
SCHEMBL14820284 0.80 PARP1 (0.47) ALDH1A1HPGDF2GLACYP11B1
SCHEMBL16564027 0.77 KMT2A (0.42) ALDH1A1HPGDF2GLASMN1; SMN2
SCHEMBL15142128 0.77 GCK (0.39) ALDH1A1HPGDF2GLACYP3A4
SCHEMBL24922537 0.77 ALDH1A1 (0.39) ALDH1A1HPGDF2GLACES2
SCHEMBL31530604 0.75 P2RX7 (0.53) ALDH1A1HPGDCYP3A4SMN1; SMN2CYP1A2
SCHEMBL24922535 0.74 SIRT6 (0.44) ALDH1A1SMN1; SMN2CYP1A2MAPTNPC1
SCHEMBL25406148 0.74 KMT2A (0.44) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 — — WO disclosed
US-8008487-B2 Substituted thieno[2,3-D]pyrimidines as fungicides DOW AGROSCIENCES LLC (US) 2011-08-30 — — US disclosed
US-8008487-B2 Substituted thieno[2,3-D]pyrimidines as fungicides DOW AGROSCIENCES LLC (US) 2011-08-30 — — US disclosed
US-8008487-B2 Substituted thieno[2,3-D]pyrimidines as fungicides DOW AGROSCIENCES LLC (US) 2011-08-30 — — US disclosed
EP-1802632-B1 THIENO-PYRIMIDINE COMPOUNDS HAVING FUNGICIDAL ACTIVITY DOW AGROSCIENCES LLC (US) 2011-07-13 — — EP disclosed
US-20060089370-A1 Thieno-pyrimidine compounds having fungicidal activity BREWSTER WILLIAM K 2006-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089370-A1 Thieno-pyrimidine compounds having fungicidal activity TYMP, DPM1, TYMS ALDH1A1 539/4885HPGD 1200/4885F2 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.